AbbVie (ABBV) Total Debt (2012 - 2026)

AbbVie (ABBV) has 15 years of Total Debt data on file, last reported at $64.5 billion in Q1 2026.

• Total Debt for Q1 2026 came in at $64.5 billion, down 5.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.5 billion (down 5.51% YoY), and the FY2025 annual result was $61.4 billion, down 8.5% from the prior year.
• Total Debt climbed to $64.5 billion in Q1 2026 per ABBV's latest filing, from $61.4 billion in the prior quarter.
• Over five years, Total Debt peaked at $72.9 billion in Q2 2022 and troughed at $55.8 billion in Q2 2023.
• A 5-year average of $64.4 billion and a median of $63.8 billion in 2024 frame the typical range for Total Debt.
• The sharpest annual moves came in 2022 and 2024: Total Debt retreated 25.71% in 2022, then advanced 26.56% in 2024.
• A 5-year view of Total Debt shows it stood at $63.3 billion in 2022, then dropped by 6.14% to $59.4 billion in 2023, then gained by 13.07% to $67.1 billion in 2024, then decreased by 8.5% to $61.4 billion in 2025, then gained by 5.03% to $64.5 billion in 2026.
• Business Quant data shows ABBV's Total Debt at $64.5 billion in Q1 2026, $61.4 billion in Q4 2025, and $65.0 billion in Q3 2025.